Rigel Pharma Misses Q1 EPS by 2c

  • Investing.com
Rigel Pharma Misses Q1 EPS by 2c

Rigel Pharma (NASDAQ: RIGL ) reported Q1 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $16.74 million versus the consensus estimate of $17.54 million.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles